Abstracts

Citation

Functionality and Determinants of Antibody Responses to H1N1 pandemic Inactivated Vaccine (pH1N1 vaccine) in HIV-Infected Children, Adolescents and Youth. Presented at: IDWeek 2013.

Citation

Omitting NRTIs from ARV regimens is not inferior to adding NRTIs in treatment experienced HIV+ subjects failing a PI regimen: The ACTG OPTIONS study. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Citation

Absent HIV-Specific Immune Responses and Replication-Competent HIV- Reservoirs in Perinatally-Infected Youth treated from Infancy: Towards Cure. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Citation

Functional HIV Cure after Very Early Antiretroviral Therapy of an Infected Infant. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Citation

24 and 48 Week Results from IMPAACT P1066: Raltegravir (RAL) Granules for Suspension (GFS) Formulation in Infants 4 Weeks (wks) to 6 Months (mos) of age. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Citation

Efficacy and safety of 6 months versus 6 weeks extended nevirapine (NVP) for prevention of postnatal HIV-1 transmission (PMTCT): 18 month follow-up of the HPTN 046 randomized double blind placebo controlled trial. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Citation

Severe immunodeficiency in children starting ART in low-, middle- and high-income countries. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Citation

Microarray analysis reveals novel insights into immunity to H1N1/09 influenza vaccine in HIV infected children and adolescents in IMPAACT protocol 1088. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Citation

Higher Regulatory B and T Cell Rates Are Associated with Decreased Immune Responses to pH1N1 Influenza Vaccine in HIV-Infected Children and Youth. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Citation

Pharmacokinetics of Lopinavir/ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines: Interim Results from IMPAACT P1083. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.